Article Information
PMID
Published By
Print ISSN
0258-851X
Online ISSN
1791-7549
History
- Received July 18, 2017
- Revision received August 7, 2017
- Accepted August 8, 2017
- Published online September 7, 2017.
Copyright & License
Copyright © 2017 The Author(s). Published by the International Institute of Anticancer Research.
Author Information
- TOSHIYA MAEKURA1⇑,
- MAIKO NAITO1,
- MASAHIRO TAHARA1,
- NAOYA IKEGAMI1,
- YOHEI KIMURA1,
- SHOKO SONOBE1,
- TAKEHIKO KOBAYASHI1,
- TAISUKE TSUJI1,
- SHOJIRO MINOMO1,
- AKIHIRO TAMIYA1 and
- SHINJI ATAGI2
- 1Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan
- 2Department of Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan
- Correspondence to: Dr. Toshiya Maekura, Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180 Nagasone-Cho, Kita-Ku, Sakai City, Osaka 591-8555, Japan. Tel: +81 722523021, Fax: +81 722511372, e-mail: toshiya1027{at}gmail.com
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Identification of conserved immune-related adverse event risk factors and clinical outcomes in a pan-immunotherapy data mart
- Identification of Conserved Immune-Related Adverse Event Risk Factors and Clinical Outcomes in a Pan-Immunotherapy Data Mart
- The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders
- Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism